The Impact of COVID-19 Pandemic on Treatment, Follow-up and Behavioral Characteristics of Chronic Viral Hepatitis Patients

被引:0
作者
Saricaoglu, Elif M. [1 ]
Kayaaslan, Bircan [2 ]
Guner, Rahmet [2 ]
机构
[1] Ankara City Hosp, Clin Infect Dis & Clin Microbiol, Ankara, Turkey
[2] Ankara Yildirim Beyazit Univ, Clin Infect Dis & Clin Microbiol, Ankara City Hosp, Ankara, Turkey
来源
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL | 2020年 / 26卷 / 02期
关键词
Anxiety; chronic viral hepatitis; COVID-19; OUTBREAK; HEALTH;
D O I
10.4274/vhd.galenos.2020.2019.0019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: It has been not yet fully understood whether chronic liver diseases may be considered as risk factors for critical course of Coronavirus disease-2019 (COVID-19). Considering the importance of managing with COVID-19, we aimed to investigate the impact of the COVID-19 pandemic on treatment, follow-up and behavioral characteristics of chronic viral hepatitis (CVH) patients. Materials and Methods: Patients followed-up in our clinic with diagnosis of chronic hepatitis B or C were screened retrospectively and a total 213 adults included in the study. We performed a telephone survey with patients. Results: The mean age of participants was 49.9 +/- 13.4 years. Of the participants, 62% were male. Totally 75 (35.2%) patients disrupted their follow-up visits due to COVID-19 pandemic. The only risk factor for disruption in follow-up was found as anxiety. The vast majority of CVH patients paid attention to prevention measures for COVID-19. Conclusion: We can say that CVH patients' awareness about COVID-19 and application of control measures were well enough. Continuity of treatment can be provided in patients with chronic illness during crisis period with informing patients in a way not to cause anxiety and efficient implementations in healthcare system.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 21 条
  • [1] [Anonymous], 2020, COVID-19 (SARS-CoV-2 Infection) Laboratory Biosafety Guide
  • [2] [Anonymous], 2020, COVID 19 TEDBIRI KRO
  • [3] [Anonymous], 2020, INT J ENV RES PUB HE, DOI DOI 10.3390/ijerph17072459
  • [4] Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
    Boettler, Tobias
    Newsome, Philip N.
    Mondelli, Mario U.
    Maticic, Mojca
    Cordero, Elisa
    Cornberg, Markus
    Berg, Thomas
    [J]. JHEP REPORTS, 2020, 2 (03)
  • [5] Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS)
    Cheng, SKW
    Wong, CW
    Tsang, J
    Wong, KC
    [J]. PSYCHOLOGICAL MEDICINE, 2004, 34 (07) : 1187 - 1195
  • [6] Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397
  • [7] COVID-19 outbreak control, example of ministry of health of Turkey
    Demirbilek, Yasemin
    Pehlivanturk, Gulen
    Ozguler, Zeynep Ozge
    Alp Mese, Emine
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 489 - 494
  • [8] Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience
    Fiorino, Gionata
    Allocca, Mariangela
    Furfaro, Federica
    Gilardi, Daniela
    Zilli, Alessandra
    Radice, Simona
    Spinelli, Antonino
    Danese, Silvio
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (09) : 1330 - 1333
  • [9] The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China
    Fu, Jianhon
    Kong, Jindan
    Wang, Wei
    Wu, Meiying
    Yao, Lin
    Wang, Zhaoyue
    Jin, Jun
    Wu, Deipei
    Yu, Xin
    [J]. THROMBOSIS RESEARCH, 2020, 192 : 3 - 8
  • [10] Guan W-J, 2020, CLIN CHARACTERISTICS, V382, P1708, DOI DOI 10.1056/NEJMOA2002032